Exact Mass: 490.205
Exact Mass Matches: 490.205
Found 171 metabolites which its exact mass value is equals to given mass value 490.205
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cymorcin diglucoside
Cymorcin diglucoside is a constituent of fruit of Carum ajowan (ajowan). Constituent of fruit of Carum ajowan (ajowan)
Gly-arg-gly-asp-ser
Pemafibrate
3-(4-Hydroxyphenyl)-5-methoxy-6-(3,3-dimethylallyl)-2,2-dimethylchromene-(5,6:8,7)-3-(propyl-2-one)-4H-1-benzo-2,3-dihydropyran-2,4-dione
8-Prenyllepidissipyrone
3-(4-Hydroxyphenyl)-5-methoxy-8,8-dimethyl-6-(3-methyl-2-butenyl)-3-(2-oxopropyl)-2H,8H-benzo[1,2-b:3,4-b]dipyran-2,4(3H)-dione
(2S,3S)-1-phenyl-2,3-butanediol 2-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|everlastoside K
Me glycoside,2,3-O-isopropylidene,2,3,4-tri-Ac-4-O-alpha-L-Rhamnopyranosyl-L-rhamnose
6-Hydroxythymol 3,6-di-O-??-D-glucopyranoside|7-hydroxythymol 3,6-di-O-beta-D-glucopyranoside|thymoquinol 2,5-O-beta-diglucopyranoside
Asn Thr Gln Glu
[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate
Asp Asp Lys Asn
Asp Asp Asn Lys
Asp Lys Asp Asn
Asp Lys Asn Asp
Asp Asn Asp Lys
Asp Asn Lys Asp
Asp Asn Arg Ser
Asp Asn Ser Arg
Asp Pro Pro Tyr
Asp Pro Tyr Pro
Asp Gln Gln Thr
Asp Gln Thr Gln
Asp Arg Asn Ser
Asp Arg Ser Asn
Asp Ser Asn Arg
Asp Ser Arg Asn
Asp Thr Gln Gln
Asp Tyr Pro Pro
Glu Asn Gln Thr
Glu Asn Thr Gln
Glu Gln Asn Thr
Glu Gln Gln Ser
Glu Gln Ser Gln
Glu Gln Thr Asn
Glu Ser Gln Gln
Glu Thr Asn Gln
Glu Thr Gln Asn
Phe Gly His Met
Phe Gly Met His
Phe His Gly Met
Phe His Met Gly
Phe Met Gly His
Phe Met His Gly
Gly Phe His Met
Gly Phe Met His
Gly His Phe Met
Gly His Met Phe
Gly Met Phe His
Gly Met His Phe
His Phe Gly Met
His Phe Met Gly
His Gly Phe Met
His Gly Met Phe
His Met Phe Gly
His Met Gly Phe
Lys Asp Asp Asn
Lys Asp Asn Asp
Lys Asn Asp Asp
Met Phe Gly His
Met Phe His Gly
Met Gly Phe His
Met Gly His Phe
Met His Phe Gly
Met His Gly Phe
Asn Asp Asp Lys
Asn Asp Lys Asp
Asn Asp Arg Ser
Asn Asp Ser Arg
Asn Glu Gln Thr
Asn Glu Thr Gln
Asn Lys Asp Asp
Asn Gln Glu Thr
Asn Gln Thr Glu
Asn Arg Asp Ser
Asn Arg Ser Asp
Asn Ser Asp Arg
Asn Ser Arg Asp
Asn Thr Glu Gln
Pro Asp Pro Tyr
Pro Asp Tyr Pro
Pro Pro Asp Tyr
Pro Pro Tyr Asp
Pro Tyr Asp Pro
Pro Tyr Pro Asp
Gln Asp Gln Thr
Gln Asp Thr Gln
Gln Glu Asn Thr
Gln Glu Gln Ser
Gln Glu Ser Gln
Gln Glu Thr Asn
Gln Asn Glu Thr
Gln Asn Thr Glu
Gln Gln Asp Thr
Gln Gln Glu Ser
Gln Gln Ser Glu
Gln Gln Thr Asp
Gln Ser Glu Gln
Gln Ser Gln Glu
Gln Thr Asp Gln
Gln Thr Glu Asn
Gln Thr Asn Glu
Gln Thr Gln Asp
Arg Asp Asn Ser
Arg Asp Ser Asn
Arg Asn Asp Ser
Arg Asn Ser Asp
Arg Ser Asp Asn
Arg Ser Asn Asp
Ser Asp Asn Arg
Ser Asp Arg Asn
Ser Glu Gln Gln
Ser Asn Asp Arg
Ser Asn Arg Asp
Ser Gln Glu Gln
Ser Gln Gln Glu
Ser Arg Asp Asn
Ser Arg Asn Asp
Thr Asp Gln Gln
Thr Glu Asn Gln
Thr Glu Gln Asn
Thr Asn Glu Gln
Thr Asn Gln Glu
Thr Gln Asp Gln
Thr Gln Glu Asn
Thr Gln Asn Glu
Thr Gln Gln Asp
Tyr Asp Pro Pro
Tyr Pro Asp Pro
Tyr Pro Pro Asp
Cymorcin diglucoside
H-Gly-Arg-Gly-Asp-Ser-OH
Gly-Arg-Gly-Asp-Ser (GRGDS) is a pentapeptide that forms the cell-binding domain of a glycoprotein, osteopontin. Gly-Arg-Gly-Asp-Ser binds to integrin receptors αvβ3 and αvβ5 with estimated IC50 of ~5 and ~6.5 μM[1]
9,9-bis-(4-Hydroxy-3-methylphenyl)fluorene diglycidyl ether
N,N-BIS(2-HYDROXYETHYL)-p-PHENYLENEDIAMINE SULFATE
Pemafibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Pemafibrate is a highly selective PPARα agonist, with an EC50 of 1 nM.
Glasdegib maleate
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
[3,4,5-Trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate
2-[[2-[3-(1-azepanylsulfonyl)-4-methylanilino]-2-oxoethyl]-methylamino]-N-(3-fluorophenyl)acetamide
(2S,3S,3aR,9bR)-N-ethyl-7-(4-fluorophenyl)-3-(hydroxymethyl)-6-oxo-1-[1-oxo-2-(3-pyridinyl)ethyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-N-ethyl-7-(4-fluorophenyl)-3-(hydroxymethyl)-6-oxo-1-[1-oxo-2-(3-pyridinyl)ethyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-1-(2-fluorobenzoyl)-3-(hydroxymethyl)-6-oxo-N-propyl-7-pyridin-3-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
(2R,3R,3aS,9bS)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-6-oxo-N-propyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
2-[(4-{[(3,4-dihydroxy-5,6-dimethyloxan-2-yl)oxy]methyl}-5-hydroxy-1h,4ah,5h,7ah-cyclopenta[c]pyran-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(3-hydroxy-1-phenylbutan-2-yl)oxy]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1s,4as,5r,7ar)-4-({[(2r,3r,4s,5s,6r)-3,4-dihydroxy-5,6-dimethyloxan-2-yl]oxy}methyl)-5-hydroxy-1h,4ah,5h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3s)-3-(4-hydroxyphenyl)-5-methoxy-8,8-dimethyl-6-(3-methylbut-2-en-1-yl)-3-(2-oxopropyl)pyrano[2,3-f]chromene-2,4-dione
(2r,3r,4s,5s,6r)-2-{[(2s,3s)-3-hydroxy-1-phenylbutan-2-yl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
6-hydroxythymol 3,6-di-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN012473","Ingredient_name": "6-hydroxythymol 3,6-di-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C22H34O12","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10762","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}